Robert E. Sell, Group Chief Exec-Com, Med & Technology at Accenture plc (ACN), sold 595 shares at $87.52 ($52K) on 2015-01-05, disclosed to the SEC on 2015-01-07.
Scheduled sale ($52k) by Group Chief Exec-Com, Med & Technology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACN | SELL | 2017-12-27 | $573K | — | Filing → |
| ACN | SELL | 2017-10-03 | $469K | — | Filing → |
| ACN | SELL | 2017-06-27 | $369K | — | Filing → |